Based on 1 analyst offering 12 month price targets for Microbot Medical Inc
Min Forecast
$9.00+243.51%
Avg Forecast
$9.00+243.51%
Max Forecast
$9.00+243.51%
Should I buy or sell MBOT stock?
Based on 1 analyst offering ratings for Microbot Medical Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although MBOT's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates MBOT as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More
Be the first to know when Wall Street analysts revise their MBOT stock forecasts and price targets.
Is Microbot Medical Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: MBOT) stock is to Buy MBOT stock.
Out of 1 analyst, 0 (0%) are recommending MBOT as a Strong Buy, 1 (100%) are recommending MBOT as a Buy, 0 (0%) are recommending MBOT as a Hold, 0 (0%) are recommending MBOT as a Sell, and 0 (0%) are recommending MBOT as a Strong Sell.
What is MBOT's earnings growth forecast for 2025-2025?
(NASDAQ: MBOT) Microbot Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Microbot Medical's earnings in 2025 is -$11,443,000.
In 2025, MBOT is forecast to generate -$13,897,790 in earnings, with the lowest earnings forecast at -$13,897,790 and the highest earnings forecast at -$13,897,790.
What is MBOT's revenue growth forecast for 2025-2025?
(NASDAQ: MBOT) Microbot Medical's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Microbot Medical's revenue in 2025 is $0.
In 2025, MBOT is forecast to generate $208,466,856 in revenue, with the lowest revenue forecast at $208,466,856 and the highest revenue forecast at $208,466,856.
What is MBOT's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: MBOT) forecast ROA is -230.44%, which is lower than the forecast US Medical Instruments & Supplies industry average of 9.63%.
What is MBOT's Price Target?
According to 1 Wall Street analyst that have issued a 1 year MBOT price target, the average MBOT price target is $9.00, with the highest MBOT stock price forecast at $9.00 and the lowest MBOT stock price forecast at $9.00.
The Wall Street analyst predicted that Microbot Medical's share price could reach $9.00 by Apr 10, 2026. The average Microbot Medical stock price prediction forecasts a potential upside of 243.51% from the current MBOT share price of $2.62.
What is MBOT's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: MBOT) Microbot Medical's current Earnings Per Share (EPS) is -$0.73. In 2025, MBOT's EPS is forecast to hit -$0.40 (min: -$0.40, max: -$0.40).
What is MBOT's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: MBOT) forecast ROE is -393.71%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.